marijuana stocks

Organigram & Canopy Growth partner in Newfoundland and Labrador by signing supply agreement including distribution and retail services

Organigram will become a key supplier of branded, finished cannabis products to Canopy Growth’s Tweed-branded retail operations in Newfoundland and Labrador once adult recreational cannabis is legalized in Canada on October 17 th, 2018. Canopy Growth will also perform a B2B sales function for Organigram by marketing its portfolio to other licensed retail outlets in Newfoundland and Labrador .

“We are very excited to partner with Canopy Growth in Newfoundland and Labrador ,” says Tim Emberg , Vice President of Sales and Commercial Operations, Organigram. “Canopy is a tremendous industry partner and we are looking forward to working with them to provide Newfoundlanders with an exceptional selection of quality cannabis products.”

Currently, Organigram also has supply agreements/memorandums of understanding with the provinces of New Brunswick , Nova Scotia , Prince Edward Island , Alberta , Manitoba and Ontario . Canopy has secured supply agreements in every province & territory with announced supply plans. Today’s announcement applies to Newfoundland and Labrador only and the commercial terms of the agreement not disclosed in this press release are confidential.

“Customers exploring the new cannabis retail environment will be looking for product diversity. Similar to our medical cannabis e-commerce site, offering our customers a wide product offering, focused on diverse and complementary brands, has always been a key strategy for us,” said Rade Kovacevic, EVP, Recreational Cannabis & Managing Director, Canada . “Organigram’s product selection will complement our existing product mix to provide Tweed customers with additional options in Newfoundland and Labrador .”

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada.  The company’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).  Organigram’s unprecedented recreational portfolio features brands including The Edison Cannabis Company, ANKR Organics and Trailer Park Buds.

About Canopy Growth Corporation

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

The Company has operations in 11 countries across five continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AbbVie Inc. (ABBV) Submits Application for Risankizumab (SKYRIZI®) in Moderate to Severe Crohn’s Disease

AbbVie Submits Application for Risankizumab (SKYRIZI®) in Moderate to Severe Crohn’s Disease…

$NTRR Deliver New Weapons Against Mold in Colorado’s Cannabis Industry

NTRR and S2O2 Deliver New Weapons Against Mold in Colorado’s Billion-Dollar Cannabis…

AgraFlora Organics International Inc. (AGFAF) Subsidiary Farmako Obtains Additional EU-GMP Cannabis

AgraFlora’s Subsidiary Farmako Obtains Additional EU-GMP Cannabis for Distribution in Germany AgraFlora…

InMed Pharmaceuticals Inc. (IMLFF) Reports Third Quarter Fiscal 2018 Financial Results and Provides Business Update

InMed Reports Third Quarter Fiscal 2018 Financial Results and Provides Business Update…